ADHD has long been recognized as a neurodevelopmental disorder predominantly diagnosed in children, characterized by impulsivity, hyperactivity, and inattention. However, recent epidemiological data reveal a striking rise in adult ADHD diagnoses, a phenomenon particularly evident in Estonia, where numbers have dramatically increased in the past five years. This trend aligns with international observations, suggesting that ADHD symptoms manifest persistently into adulthood or may initially emerge later in life, warranting urgent scientific attention.

Despite extensive research on pediatric ADHD, adult presentations of the disorder remain poorly understood, especially concerning their etiological complexity. Adult ADHD is complicated by the frequent presence of comorbid mental health disorders such as depression and anxiety, and overlaps symptomatically with conditions driven by environmental stressors including chronic fatigue and psychosocial pressures. This diagnostic ambiguity contributes to underdiagnosis or misdiagnosis, impeding effective treatment and negatively impacting patient outcomes.

Professor Lehto highlights a critical gap in current psychiatric practice: the absence of objective biological markers for ADHD. Presently, diagnoses depend heavily on subjective patient reports and clinical assessments, which can be inconsistent and influenced by overlapping symptomatology. This reliance underscores the necessity for novel biologically grounded diagnostic tools that can differentiate ADHD from other mental health conditions with greater precision.

The project’s core scientific innovation resides in employing high-dimensional genetic data derived from large biobanks, which include the University of Tartu’s Estonian Biobank and similar repositories across Norway, the Netherlands, Sweden, and the United Kingdom. By analyzing genome-wide association study (GWAS) data in conjunction with detailed phenotypic information encompassing lifestyle factors such as smart device usage, the research team intends to dissect the polygenic architecture of adult ADHD symptoms.

One of the major challenges the project addresses is disentangling which clinical traits are genuinely driven by underlying genetic risk factors associated with ADHD versus those attributable to external influences or comorbidities. This distinction is vital not only for understanding pathophysiology but also for developing targeted interventions. The researchers hypothesize that specific gene variants contribute differentially to discrete symptom clusters, an insight that could transform psychiatric nosology.

Employing cutting-edge machine learning algorithms, the project will analyze extensive questionnaire data capturing hundreds of mental health symptoms, personality traits, and lifestyle variables. This computational approach allows for the identification of symptom clusters that most strongly correlate with genetic susceptibility to ADHD. Such data-driven stratification aims to create a biologically informed phenotype classification rather than relying solely on traditional symptom checklists.

The culmination of these efforts will be the design of an innovative, biology-based screening tool for adult ADHD diagnosis. Importantly, the intended questionnaire format is envisioned as a cost-effective and accessible alternative to genetic testing, democratizing early and accurate detection. This advancement has the potential to revolutionize clinical workflows by enabling clinicians to identify previously undiagnosed adults who have been coping with ADHD-related impairments throughout their lives.

Beyond ADHD, Professor Lehto emphasizes that the methodology developed may have broader applications in psychiatry, where multiple disorders exhibit overlapping symptoms and shared genetic risk factors. A more precise, genetics-informed framework for diagnosing mental health conditions could improve treatment personalization and efficacy across various psychiatric illnesses.

The research is supported by a competitive European Commission grant amounting to nearly €1.5 million, underscoring the significance and expected impact of the work. The grant selection process was highly rigorous, with only 12% of proposals funded from a large pool of over 3,900 applicants, highlighting the project’s scientific excellence and innovation.

This interdisciplinary endeavor, at the interface of neuropsychiatric genomics, psychology, and data science, exemplifies a modern approach to complex mental health disorders. It leverages vast datasets and computational power to decode the intricate web of genetics and environment contributing to adult ADHD. The anticipated outcomes promise not only diagnostic innovation but also deeper mechanistic insights that could guide future therapeutic targets.

In conclusion, Kelli Lehto’s project represents a pivotal advancement in psychiatric research, pushing the boundaries of knowledge about adult ADHD and underscoring the increasing importance of integrating genetic and environmental data. The novel diagnostic tools resulting from this research could alleviate the significant burden of undiagnosed ADHD in adults, offering hope for improved quality of life through timely and tailored interventions.

Subject of Research: Genetic and environmental determinants of adult ADHD; development of biology-based diagnostic tools for adult ADHD.

Article Title: Decoding Adult ADHD: Pioneering Genetics and Machine Learning to Revolutionize Diagnosis

News Publication Date: Information not provided.

Web References: University of Tartu Estonian Biobank

References: Information not provided.

Image Credits: Photo by Andres Tennus

Keywords: Adult ADHD, neuropsychiatric genomics, genetic risk variants, machine learning, psychiatric diagnostics, biobank data, European Research Council grant, personalized medicine, neurodevelopmental disorders, mental health biomarkers

The diagnostic challenge of distinguishing between ADHD, ASD, and their co-occurrence in adults has long posed a clinical conundrum. These conditions not only share overlapping features but also diverge significantly in emotional, cognitive, and behavioral presentations. Traditionally, clinicians have relied heavily on behavioral observations and clinical interviews guided by the DSM-5 criteria. However, the value of self-reported symptom scales as complementary diagnostic tools has gained momentum, particularly in enhancing precision and personal insight prior to formal assessment.

This investigation recruited 300 adults, excluding those with intellectual developmental disorders, implementing a multidisciplinary consensus diagnostic approach. Participants included individuals diagnosed with ADHD (174), ASD (68), and those with both ADHD and ASD (58). Prior to their clinical assessments, these adults completed a battery of psychometrically validated questionnaires via an online platform, targeting distinct symptom dimensions relevant to their suspected diagnoses.

Key instruments utilized in this research were the modified Barkley Adult ADHD Rating Scale (BAARS IV) for assessing ADHD-related symptoms, the Autism Spectrum Quotient (AQ) alongside the Empathy Quotient (EQ) to evaluate autism spectrum traits and empathy levels respectively, and the Affective Lability Scale (ALS) designed to quantify mood instability. By comparing total and subscale scores across diagnostic groups, the researchers aimed to elucidate distinctive symptom constellations aiding differentiation.

The most striking revelation was that individuals with ADHD and those with comorbid ADHD + ASD exhibited significantly elevated affective lability scores relative to those diagnosed solely with ASD. This finding challenges prior assumptions that emotional dysregulation, while common across psychiatric disorders, lacks specificity in distinguishing ADHD within clinical populations. Instead, it underscores affective lability as a critical emotional dimension warranting systematic evaluation during adult ADHD assessments.

Logistic regression models further refined the discriminatory power of these scales. Differentiation between ASD and ADHD + ASD was particularly influenced by current BAARS IV scores and EQ totals, highlighting current ADHD symptom burden and empathetic capacity as pivotal features. When segregating pure ADHD from the comorbid condition, a combination of the ALS anger subscale, past BAARS IV scores, and AQ totals proved most informative, suggesting that historical ADHD symptom severity and autism trait intensity, alongside emotional reactivity, provide valuable diagnostic clues.

Distinguishing ADHD from ASD was similarly nuanced; here, past BAARS IV scores coupled with current inattention levels, AQ, and EQ scores collectively enhanced diagnostic accuracy. These findings suggest that a temporal perspective on symptom evolution, combined with empathy assessments and autism trait quantification, can clarify the often ambiguous clinical presentations where ADHD and ASD traits overlap.

The implications of this research extend beyond mere diagnostic categorization. By emphasizing emotional dimensions such as affective lability within neurodevelopmental frameworks, clinicians are encouraged to adopt a more holistic approach. Understanding mood variability alongside core cognitive and social deficits can generate richer clinical portraits, thus informing tailored therapeutic interventions and potentially improving long-term outcomes.

In light of these insights, the study advocates for integrating targeted self-report questionnaires into standard adult neurodevelopmental assessment protocols. Such an approach not only empowers patients by directly involving them in the diagnostic process but also augments clinicians’ ability to make nuanced distinctions in complex clinical cases, ultimately fostering more personalized care pathways.

Moreover, the use of online platforms for pre-assessment data collection highlights an advancing digital trend in psychiatry, promoting accessibility and efficiency. This methodological innovation also facilitates large-scale data acquisition, which is indispensable for advancing evidence-based practice in neuropsychiatric diagnostics.

While the study focused on adults without intellectual disability, future research might expand these paradigms to include wider demographic and clinical spectra, investigating how affective lability interacts with cognitive impairments or other psychiatric comorbidities. Such exploration could further unravel the multifaceted tapestry of neurodevelopmental disorders and inform more comprehensive clinical strategies.

The comprehensive nature of this research underscores the necessity of moving beyond categorical diagnoses towards dimensional and integrative models that capture the breadth of human neurodiversity. Understanding the interplay between attention, social cognition, and emotional regulation not only refines diagnostic clarity but also paves the way for innovations in treatment modalities.

Ultimately, this study marks a pivotal step in redefining adult neurodevelopmental assessment, illuminating the vital role of emotional fluctuation in teasing apart overlapping disorders. As clinicians and researchers heed these findings, we can anticipate heightened diagnostic precision, enhanced patient engagement, and, importantly, improved quality of life for those navigating the complexities of ADHD, ASD, and their intersection.

Subject of Research: Adult self-reported symptoms and affective lability in differentiating ADHD, ASD, and their co-occurrence.

Article Title: Self-reported symptoms of attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and affective lability in discriminating adult ADHD, ASD and their co-occurrence.

Article References:
Pehlivanidis, A., Kouklari, E. C., Kalantzi, E. et al. Self-reported symptoms of attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and affective lability in discriminating adult ADHD, ASD and their co-occurrence. BMC Psychiatry 25, 391 (2025). https://doi.org/10.1186/s12888-025-06841-0

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12888-025-06841-0